News
- Author:
- Mark S. Lesney
Publish date: May 16, 2021
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.
News
- Author:
- Mark S. Lesney
Publish date: June 26, 2020
CPX-351 therapy was tied to long-term remission and survival in older patients with newly diagnosed high-risk or ...
News
- Author:
- Mark S. Lesney
Publish date: May 22, 2020
The new formulation of twice-a-day Ferriprox 1,000 mg oral tablets eliminates the midday dose.
News
- Author:
- Mark S. Lesney
Publish date: May 21, 2020
Vaccination was effective despite the expected decrease in immunological response during target and immunotherapy...
News
- Author:
- Mark S. Lesney
Publish date: May 20, 2020
Urban non Hispanic blacks and Hispanics have an increased incidence of CLL, DLBCL, respectively vs. rural....
News
- Author:
- Mark S. Lesney
Publish date: May 14, 2020
Adult patients with secondary ALL had poorer overall survival than de novo ALL patients.
News
- Author:
- Mark S. Lesney
Publish date: May 12, 2020
Vitamin D3 prophylaxis is a safe practice in sickle cell disease, and it is important to start this prophylactic treatment when the child is an inf...
News
- Author:
- Mark S. Lesney
Publish date: May 11, 2020
Researchers suggested that academic centers might provide increased access to clinical trials, improved physician expertise, improved treatment fac...
News
- Author:
- Mark S. Lesney
Publish date: May 6, 2020
Interleukin-27 was able to increase cytotoxic effects of bone marrow natural killer cells in chronic lymphocytic leukemia (CLL).
News
- Author:
- Mark S. Lesney
Publish date: April 27, 2020
SARS-CoV-2 is present significantly longer in samples from severe COVID-19 patients than from patients with mild ...
News
- Author:
- Mark S. Lesney
Publish date: April 23, 2020
Melflufen plus dexamethasone showed activity in patients with relapsed/refractory multiple myeloma.
News
- Author:
- Mark S. Lesney
Publish date: April 22, 2020
Ruxolitinib was significantly more effective against acute graft-versus-host disease but produced more thrombocytopenia than did control treatment....
News
- Author:
- Mark S. Lesney
Publish date: April 22, 2020
None of the indexes was able to predict with total precision the clinical evolution of Binet A chronic lymphocyti...
News
- Author:
- Mark S. Lesney
Publish date: April 20, 2020
Thalassemia patients appeared to fare relatively well after COVID-19 diagnosis in anecdotal series reports from E...
News
- Author:
- Mark S. Lesney
Publish date: April 17, 2020
High response rates and effective bridge to transplant shown.
